Table 2.
Experimental groups
| Groups | Drug administered | Dosage and route |
|---|---|---|
| 1 | Control | 2 ml NS, orally |
| 2 | STZ | 35 mg/kg, i.p |
| 3 | STZ + donepezil | 35 mg/kg, i.p + 1 mg/kg, orally |
| 4 | STZ + vitamin D | 35 mg/kg, i.p + 27mcg/kg, orally |
| 5 | STZ + epalrestat | 35 mg/kg, i.p + 57 mg/kg, orally |
| 6 | STZ + (vitamin D + epalrestat) | 35 mg/kg, i.p + (27mcg/kg, orally + 57 mg/kg, orally) |
| 7 | STZ + scopolamine | 35 mg/kg, i.p + 0.5 mg/kg, i.p |
| 8 | (STZ + scopolamine) + donepezil | (35 mg/kg, i.p + 0.5 mg/kg, i.p) + 1 mg/kg, orally |
| 9 | (STZ + scopolamine) + vitamin D | (35 mg/kg, i.p + 0.5 mg/kg, i.p) + 27mcg/kg, orally |
| 10 | (STZ + scopolamine) + epalrestat | (35 mg/kg, i.p + 0.5 mg/kg, i.p) + 57 mg/kg, orally |
| 11 | (STZ + scopolamine) + (vitamin D and epalrestat) | (35 mg/kg, i.p + 0.5 mg/kg, i.p) + (27mcg/kg, orally + 57 mg/kg, orally) |